Actively Recruiting
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Led by Merck Sharp & Dohme LLC · Updated on 2026-05-11
150
Participants Needed
55
Research Sites
331 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers want to learn if calderasib given alone or with cetuximab can treat certain advanced solid tumors in people with the KRAS G12C mutation. The goals of this study are to learn: * How many people have the cancer respond (get smaller or go away) to calderasib alone or with cetuximab and how these responses compare * About the safety of calderasib alone or with cetuximab and if people tolerate the treatments.
CONDITIONS
Official Title
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Has locally advanced unresectable or metastatic solid tumor malignancy other than colorectal cancer and has progressed on, or following, standard of care systemic treatment
- Has a tumor that demonstrates the presence of Kirsten rat sarcoma (KRAS) G12C mutation
You will not qualify if you...
- Has uncontrolled, significant cardiovascular disease or cerebrovascular disease
- Has known additional malignancy that is progressing or has required active treatment within the past 3 years
- Has known active central nervous system metastases and/or carcinomatous meningitis and/or primary brain tumors
- Has active infection, other than those permitted per protocol, requiring systemic therapy
- Has not adequately recovered from major surgery or has ongoing surgical complications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 55 locations
1
Greater Baltimore Medical Center ( Site 1104)
Baltimore, Maryland, United States, 21204
Actively Recruiting
2
START Midwest ( Site 1103)
Grand Rapids, Michigan, United States, 49546
Actively Recruiting
3
Comprehensive Cancer Centers of Nevada ( Site 1109)
Las Vegas, Nevada, United States, 89169
Actively Recruiting
4
Rutgers Cancer Institute of New Jersey ( Site 1100)
New Brunswick, New Jersey, United States, 08903
Actively Recruiting
5
START Mountain Region ( Site 1106)
West Valley City, Utah, United States, 84119
Actively Recruiting
6
Virginia Cancer Specialists ( Site 1102)
Fairfax, Virginia, United States, 22031
Actively Recruiting
7
Prince of Wales Hospital-Medical Oncology ( Site 1003)
Randwick, New South Wales, Australia, 2031
Actively Recruiting
8
Westmead Hospital ( Site 1000)
Westmead, New South Wales, Australia, 2145
Actively Recruiting
9
Epworth Freemasons ( Site 1004)
Melbourne, Victoria, Australia, 3002
Actively Recruiting
10
FALP ( Site 1200)
Santiago, Region M. de Santiago, Chile, 7500921
Actively Recruiting
11
Centro de Oncología de Precisión ( Site 1202)
Santiago, Region M. de Santiago, Chile, 7560908
Actively Recruiting
12
Clinica San Carlos de Apoquindo ( Site 1203)
Santiago, Region M. de Santiago, Chile, 7620002
Actively Recruiting
13
Bradfordhill ( Site 1201)
Santiago, Region M. de Santiago, Chile, 8420383
Actively Recruiting
14
Beijing Cancer hospital ( Site 1318)
Beijing, Beijing Municipality, China, 100142
Actively Recruiting
15
The First Affiliated Hospital of Xiamen University ( Site 1304)
Xiamen, Fujian, China, 361003
Actively Recruiting
16
Sun Yat-sen University Cancer Center ( Site 1303)
Guangzhou, Guangdong, China, 510060
Actively Recruiting
17
Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 1326)
Wuhan, Hubei, China, 430000
Actively Recruiting
18
Jiangsu Province Hospital ( Site 1324)
Nanjing, Jiangsu, China, 210029
Actively Recruiting
19
Jinan Central Hospital ( Site 1313)
Jinan, Shandong, China, 250013
Actively Recruiting
20
Shanghai Chest Hospital ( Site 1300)
Shanghai, Shanghai Municipality, China, 200030
Actively Recruiting
21
Fudan University Shanghai Cancer Center ( Site 1325)
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
22
Zhongshan Hospital,Fudan University ( Site 1301)
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
23
Zhejiang Cancer Hospital ( Site 1311)
Hangzhou, Zhejiang, China, 310022
Actively Recruiting
24
Taizhou Hospital of Zhejiang Province ( Site 1312)
Linhai, Zhejiang, China, 317000
Actively Recruiting
25
Rigshospitalet ( Site 1403)
Copenhagen, Capital Region, Denmark, 2100
Actively Recruiting
26
Odense Universitetshospital ( Site 1401)
Odense, Region Syddanmark, Denmark, 5000
Actively Recruiting
27
Universitätsklinikum Leipzig ( Site 1602)
Leipzig, Saxony, Germany, 04103
Actively Recruiting
28
Universitätsklinikum Jena ( Site 1603)
Jena, Thuringia, Germany, 07747
Actively Recruiting
29
European Interbalkan Medical Center-Oncology Department ( Site 1700)
Thessaloniki, Greece, 57001
Actively Recruiting
30
Emek Medical Center ( Site 1800)
Afula, Israel, 1834111
Actively Recruiting
31
Hadassah Medical Center ( Site 1801)
Jerusalem, Israel, 9112001
Actively Recruiting
32
Sourasky Medical Center ( Site 1802)
Tel Aviv, Israel, 6423906
Actively Recruiting
33
Istituto Clinico Humanitas-U.O di Oncologia medica ed Ematologia ( Site 1902)
Rozzano, Milano, Italy, 20089
Actively Recruiting
34
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1900)
Milan, Italy, 20133
Actively Recruiting
35
Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1901)
Roma, Italy, 00168
Actively Recruiting
36
Haukeland universitetssykehus ( Site 2102)
Bergen, Hordaland, Norway, 5021
Actively Recruiting
37
Oslo universitetssykehus, Radiumhospitalet ( Site 2101)
Oslo, Norway, 0379
Actively Recruiting
38
MTZ Clinical Research powered by Pratia ( Site 2205)
Warsaw, Masovian Voivodeship, Poland, 02-172
Actively Recruiting
39
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 2200)
Warsaw, Masovian Voivodeship, Poland, 02-781
Actively Recruiting
40
Szpital Wojewodzki im. Mikolaja Kopernika w Koszalinie ( Site 2203)
Koszalin, West Pomeranian Voivodeship, Poland, 75-581
Actively Recruiting
41
Seoul National University Hospital ( Site 2301)
Seoul, South Korea, 03080
Actively Recruiting
42
Asan Medical Center ( Site 2302)
Seoul, South Korea, 05505
Actively Recruiting
43
Samsung Medical Center ( Site 2300)
Seoul, South Korea, 06351
Actively Recruiting
44
Hospital Virgen de la Victoria ( Site 2403)
Málaga, Malaga, Spain, 29010
Actively Recruiting
45
Hospital Universitari Vall d Hebron ( Site 2401)
Barcelona, Spain, 08035
Actively Recruiting
46
Hospital Clinic de Barcelona ( Site 2402)
Barcelona, Spain, 08036
Actively Recruiting
47
Hospital Clinico San Carlos ( Site 2404)
Madrid, Spain, 28040
Actively Recruiting
48
Karolinska Universitetssjukhuset Solna ( Site 2501)
Stockholm, Stockholm County, Sweden, 171 64
Actively Recruiting
49
Sahlgrenska Universitetssjukhuset. ( Site 2502)
Gothenburg, Västra Götaland County, Sweden, 413 45
Actively Recruiting
50
Adana Medical Park Seyhan Hastanesi ( Site 2706)
Adana, Turkey (Türkiye), 01140
Actively Recruiting
51
Gazi Universitesi Tip Fakultesi Hastanesi ( Site 2702)
Ankara, Turkey (Türkiye), 06560
Actively Recruiting
52
Hacettepe Universitesi-oncology hospital ( Site 2700)
Ankara, Turkey (Türkiye), 6230
Actively Recruiting
53
Koc University Hospital ( Site 2704)
Istanbul, Turkey (Türkiye), 34010
Actively Recruiting
54
Royal Free Hospital ( Site 2801)
London, Camden, United Kingdom, NW3 2QG
Actively Recruiting
55
The Christie NHS Foundation Trust ( Site 2803)
Manchester, United Kingdom, M20 4BX
Actively Recruiting
Research Team
T
Toll Free Number
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here